These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21924382)

  • 1. A comparison of statistical approaches for physician-randomized trials with survival outcomes.
    Stedman MR; Lew RA; Losina E; Gagnon DR; Solomon DH; Brookhart MA
    Contemp Clin Trials; 2012 Jan; 33(1):104-15. PubMed ID: 21924382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of statistical approaches for analyzing physician-randomized quality improvement interventions.
    Stedman MR; Gagnon DR; Lew RA; Solomon DH; Brookhart MA
    Contemp Clin Trials; 2008 Sep; 29(5):687-95. PubMed ID: 18571476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A positive stable frailty model for clustered failure time data with covariate-dependent frailty.
    Liu D; Kalbfleisch JD; Schaubel DE
    Biometrics; 2011 Mar; 67(1):8-17. PubMed ID: 20528861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonproportional hazards and unobserved heterogeneity in clustered survival data: When can we tell the difference?
    Balan TA; Putter H
    Stat Med; 2019 Aug; 38(18):3405-3420. PubMed ID: 31050028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simulation study comparing the power of nine tests of the treatment effect in randomized controlled trials with a time-to-event outcome.
    Royston P; B Parmar MK
    Trials; 2020 Apr; 21(1):315. PubMed ID: 32252820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The type I error and power of non-parametric logrank and Wilcoxon tests with adjustment for covariates--a simulation study.
    Jiang H; Symanowski J; Paul S; Qu Y; Zagar A; Hong S
    Stat Med; 2008 Dec; 27(28):5850-60. PubMed ID: 18759373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. geecure: An R-package for marginal proportional hazards mixture cure models.
    Niu Y; Wang X; Peng Y
    Comput Methods Programs Biomed; 2018 Jul; 161():115-124. PubMed ID: 29852954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introducing a new estimator and test for the weighted all-cause hazard ratio.
    Ozga AK; Rauch G
    BMC Med Res Methodol; 2019 Jun; 19(1):118. PubMed ID: 31185922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of survival distributions in clinical trials: A practical guidance.
    Chen X; Wang X; Chen K; Zheng Y; Chappell RJ; Dey J
    Clin Trials; 2020 Oct; 17(5):507-521. PubMed ID: 32594788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bridged parametric survival models: General paradigm and speed improvements.
    Swihart BJ; Bandyopadhyay D
    Comput Methods Programs Biomed; 2021 Jul; 206():106115. PubMed ID: 33992900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of analytical strategies for cluster randomized trials with survival outcomes in the presence of competing risks.
    Li F; Lu W; Wang Y; Pan Z; Greene EJ; Meng G; Meng C; Blaha O; Zhao Y; Peduzzi P; Esserman D
    Stat Methods Med Res; 2022 Jul; 31(7):1224-1241. PubMed ID: 35290139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weighted logrank tests for interval censored data when assessment times depend on treatment.
    Fay MP; Shih JH
    Stat Med; 2012 Dec; 31(28):3760-72. PubMed ID: 22786795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Random-effects, fixed-effects and the within-between specification for clustered data in observational health studies: a simulation study.
    Dieleman JL; Templin T
    PLoS One; 2014; 9(10):e110257. PubMed ID: 25343620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mixed model for repeated measures for cluster randomized trials: a simulation study investigating bias and type I error with missing continuous data.
    Bell ML; Rabe BA
    Trials; 2020 Feb; 21(1):148. PubMed ID: 32033617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Approaches to Analyzing Continuous Correlated Eye Data When Sample Size Is Small.
    Huang J; Huang J; Chen Y; Ying GS
    Ophthalmic Epidemiol; 2018 Feb; 25(1):45-54. PubMed ID: 28891730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rank tests for clustered survival data when dependent subunits are randomized.
    Jeong JH; Jung SH
    Stat Med; 2006 Feb; 25(3):361-73. PubMed ID: 16158408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robustness of a parametric model for informatively censored bivariate longitudinal data under misspecification of its distributional assumptions: A simulation study.
    Pantazis N; Touloumi G
    Stat Med; 2007 Dec; 26(30):5473-85. PubMed ID: 18058854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restricted mean survival time: Does covariate adjustment improve precision in randomized clinical trials?
    Karrison T; Kocherginsky M
    Clin Trials; 2018 Apr; 15(2):178-188. PubMed ID: 29502444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of population-averaged and cluster-specific models for the analysis of cluster randomized trials with missing binary outcomes: a simulation study.
    Ma J; Raina P; Beyene J; Thabane L
    BMC Med Res Methodol; 2013 Jan; 13():9. PubMed ID: 23343209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of permutation and mixed-model regression methods for the analysis of simulated data in the context of a group-randomized trial.
    Murray DM; Hannan PJ; Pals SP; McCowen RG; Baker WL; Blitstein JL
    Stat Med; 2006 Feb; 25(3):375-88. PubMed ID: 16143991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.